Amity Global Institute Achieves 4-Year EduTrust Certification Renewal, Business News
Business News

Amity Global Institute Achieves 4-Year EduTrust Certification Renewal, Business News

Business new tamfitronics SINGAPORE - Media OutReach Newswire - 29 July 2024 - Amity Global Institute is proud to announce the successful renewal of its 4-year EduTrust Certification for the third consecutive term, awarded by the Committee for Private Education (CPE), part of SkillsFuture Singapore (SSG). This prestigious certification underscores our unwavering commitment to excellence in education and institutional management.The EduTrust Certification is a quality assurance scheme awarded to Private Education Institutions (PEIs) that demonstrate exemplary performance in managing their institutions and providing high-quality education and student welfare. The certification process evaluates institutions across seven key criteria: management commitment and responsibilities, corporate governance, student protection and support services, academic processes and student assessment, achievement of student and graduate outcomes, quality assurance, and continual improvement.In their assessment, the CPE commended Amity Global Institute for...
Continue reading
Menarini Announces Positive Topline Data from Pivotal Phase 3 BROOKLYN Clinical Trial Evaluating Efficacy, Safety and Tolerability of Obicetrapib in Patients with Heterozygous Familial Hypercholesterolemia, Business News
Business News

Menarini Announces Positive Topline Data from Pivotal Phase 3 BROOKLYN Clinical Trial Evaluating Efficacy, Safety and Tolerability of Obicetrapib in Patients with Heterozygous Familial Hypercholesterolemia, Business News

Business new tamfitronics --Achieved primary endpoint of LS mean reduction in LDL-C on top of maximally tolerated lipid modifying therapies at week 12 with statistically significant reduction (p<0.0001), which was sustained at week 52 (p<0.0001) -- -- Obicetrapib lowered LDL-C by 36.3% at week 12 and by 41.5% at week 52, compared to placebo -- -- Obicetrapib was well-tolerated; safety results comparable to placebo-- FLORENCE, Italy, July 29, 2024 /PRNewswire/ -- Menarini Group today announces positive topline data from the Phase 3 BROOKLYN clinical trial (NCT05425745) sponsored by NewAmsterdam Pharma Company N.V. ("NewAmsterdam"), a biopharmaceutical company which granted the Menarini Group an exclusive license to commercialize obicetrapib...
Continue reading
MAK in India: From Thiruchengode to global stage
Business News

MAK in India: From Thiruchengode to global stage

Business new tamfitronics Manickam Athappa Gounder walked six km to school for six years to clear SSLC. This farmer’s son from a small village called Pazhayapalayam in Thiruchengode taluk went on to do electronics and computer engineering (ECE) at PSG Tech in Coimbatore in the early 1970s. Over the next 50 years, he set up MAK Controls & Sytems, India, and Air MAK Industries, USA.MAK, as he now calls himself after his US exposure, has handed over the day-to-day operations of his mainstream business to a team of young professionals that includes his son.He now works with farmers in Panruti, Salem and Erode to improve productivity, walking with them to prevent pollution of Noyyal river by Tirupur dyers; supplies sewage cleaning kits for household septic tanks in cities such as Chennai; and makes paver blocks...
Continue reading